Literature DB >> 33849932

Genetic Basis of Type IV Collagen Disorders of the Kidney.

Catherine Quinlan1,2,3, Michelle N Rheault4.   

Abstract

The glomerular basement membrane is a vital component of the filtration barrier of the kidney and is primarily composed of a highly structured matrix of type IV collagen. Specific isoforms of type IV collagen, the α3(IV), α4(IV), and α5(IV) isoforms, assemble into trimers that are required for normal glomerular basement membrane function. Disruption or alteration in these isoforms leads to breakdown of the glomerular basement membrane structure and function and can lead to progressive CKD known as Alport syndrome. However, there is wide variability in phenotype among patients with mutations affecting type IV collagen that depends on a complex interplay of sex, genotype, and X-chromosome inactivation. This article reviews the genetic basis of collagen disorders of the kidney as well as potential treatments for these conditions, including direct alteration of the DNA, RNA therapies, and manipulation of collagen proteins.
Copyright © 2021 by the American Society of Nephrology.

Entities:  

Keywords:  Alport syndrome; collagen diseases; gene therapy; kidney genomics series; type IV collagen

Mesh:

Substances:

Year:  2021        PMID: 33849932      PMCID: PMC8425620          DOI: 10.2215/CJN.19171220

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN: 1555-9041            Impact factor:   10.614


  8 in total

1.  Common genetic variation associated with Mendelian disease severity revealed through cryptic phenotype analysis.

Authors:  David R Blair; Thomas J Hoffmann; Joseph T Shieh
Journal:  Nat Commun       Date:  2022-06-27       Impact factor: 17.694

Review 2.  Novel Therapies for Alport Syndrome.

Authors:  Efren Chavez; Juanly Rodriguez; Yelena Drexler; Alessia Fornoni
Journal:  Front Med (Lausanne)       Date:  2022-04-25

Review 3.  Molecular Basis, Diagnostic Challenges and Therapeutic Approaches of Alport Syndrome: A Primer for Clinicians.

Authors:  Raquel Martínez-Pulleiro; María García-Murias; Manuel Fidalgo-Díaz; Miguel Ángel García-González
Journal:  Int J Mol Sci       Date:  2021-10-14       Impact factor: 5.923

4.  Case Report: Unusual Aggregation of Different Glomerulopathies in a Family Resolved by Genetic Testing and Reverse Phenotyping.

Authors:  Reeti Kumar; Vahakn Keskinyan; Megan Chryst Stangl; Brandon M Lane; Anne F Buckley; Laura Barisoni; David N Howell; Rasheed A Gbadegesin
Journal:  Front Pediatr       Date:  2022-02-28       Impact factor: 3.418

5.  Urinary Monocyte Chemoattractant Protein-1 in Patients With Alport Syndrome.

Authors:  Clifford Kashtan; Asher Schachter; Lloyd Klickstein; Xin Liu; Lori Jennings; Nancy Finkel
Journal:  Kidney Int Rep       Date:  2022-02-01

6.  Case Report: Identification of a Novel Heterozygous Missense Mutation in COL4A3 Gene Causing Variable Phenotypes in an Autosomal-Dominant Alport Syndrome Family.

Authors:  Yanglin Hu; Wei Li; Lulu Tian; Shuai Fu; Yonglong Min; Jia Liu; Fei Xiong
Journal:  Front Genet       Date:  2022-03-29       Impact factor: 4.599

Review 7.  Biochemical composition of the glomerular extracellular matrix in patients with diabetic kidney disease.

Authors:  María M Adeva-Andany; Natalia Carneiro-Freire
Journal:  World J Diabetes       Date:  2022-07-15

Review 8.  Modeling the Glomerular Filtration Barrier and Intercellular Crosstalk.

Authors:  Kerstin Ebefors; Emelie Lassén; Nanditha Anandakrishnan; Evren U Azeloglu; Ilse S Daehn
Journal:  Front Physiol       Date:  2021-06-02       Impact factor: 4.755

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.